David Rimmer, MD
General Surgery · Bay St Louis, MSNPI 1619976636
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Johnson & Johnson at 24.3% of the total.
Across 94 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$537
- Takeda Pharmaceuticals U.S.A., Inc.$409
- Intuitive Surgical$399
- Davol Inc.$118
- TELA Bio, Inc.$77
- Conmed Corporation$71
- plus $597 from 19 others
What the payments were for
- Food & beverage$2,208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $537 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $409 |
| Intuitive Surgical | 11 | $399 |
| Davol Inc. | 2 | $118 |
| TELA Bio, Inc. | 4 | $77 |
| Conmed Corporation | 1 | $71 |
| Vertex | 3 | $63 |
| Asensus Surgical, Inc. | 3 | $61 |
| Baxter Healthcare | 3 | $57 |
| Medtronic | 2 | $56 |
| Covidien LP | 3 | $52 |
| Merck | 3 | $47 |
| Mallinckrodt Enterprises LLC | 3 | $44 |
| Cardinal Health 414 LLC | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| AbbVie | 1 | $25 |
| Focal Therapeutics, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $17 |
| Zimmer Biomet | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Merit Medical Systems Inc | 1 | $14 |
| Innocoll Pharmaceuticals Limited | 1 | $14 |
| Stryker | 1 | $14 |
| Baudax Bio Inc. | 1 | $12 |
How this compares
Too few general surgery providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $184 |
| Potassium Chloride | 11 | $117 |
| Pantoprazole Sodium | 20 | $110 |
| Famotidine | 21 | $82 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Bay St Louis
- Geoffrey FlattmannNatchez$26K
- Steven PattersonJackson$14K
- Patrick ScanlonJackson$10K
- James ChandlerJackson$7K
- Richard YelvertonJackson$5K
- Philip DoolittleGreenville$0
- Jeffery DoolittleGreenville$0
- Jaiyeola AdeleyeClarksdale$0
- Christopher LahrJackson$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.